Theramex

Activities: Drug Delivery

Trending Articles

  1. AbbVie's SKYRIZI shows positive results in Crohn's disease study The Phase III AFFIRM study in adults with moderately to severely active Crohn's disease showed superiority of risankizumab for the co-primary and ranked secondary endpoint...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    From injection to ingestion: can yeast make vaccines more accessible? As global vaccination coverage declines and distribution challenges persist, researchers are exploring edible yeast-based vaccines as a simpler, more scalable alternative to...
  3. Piramal Pharma Solutions introduces tablet-in-capsule capabilities Enhancing dosing flexibility and patient-centric drug delivery
  4. NSF Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
  5. Ananda Pharma receives MHRA and HRA approval for Phase II ENDOCAN trial in endometriosis UK biopharmaceutical company Ananda Pharma has received regulatory and ethics approval to begin a Phase II clinical trial investigating its proprietary cannabidiol (CBD)...

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

Related Content

Regulatory

Theramex selects Life Sciences Platform to digitise and streamline

The company supports the health needs of women, with products focusing on contraception, fertility, menopause, and osteoporosis
Subscribe now